Iron saturation levels in blood
Pro Research Analysisby 
Searched over 200M research papers
Iron Saturation Levels in Blood: Key Markers and Reference Ranges
Iron saturation, often measured as transferrin saturation (TSAT), is a crucial indicator of how much iron is bound to the transport protein transferrin in the blood. TSAT, along with serum iron and ferritin, helps assess iron status, detect deficiencies, and monitor for iron overload.
Reference Ranges for Iron Saturation and Serum Iron
Large cohort studies have established reference ranges for serum iron and TSAT. In healthy adults, TSAT typically ranges from about 20% to 50%, with males generally having 10–20% higher levels than females between ages 20 and 70. Serum iron and TSAT rise slightly during adolescence, with males showing higher values thereafter. These ranges are important for interpreting individual results and identifying abnormalities such as iron deficiency or overload .
In newborns, cord blood TSAT is high (about 52%), but levels drop after birth and then rebound to about half the cord value by the end of the first month of life .
Iron Saturation in Special Populations
Blood Donors
Regular blood donation can lead to lower serum iron and TSAT, especially in donors with blood group O, who tend to have the lowest levels. Monitoring TSAT and other iron markers is important to prevent iron deficiency in frequent donors. Both intravenous and oral iron supplementation can restore TSAT and ferritin levels, with intravenous iron being more effective in rapidly correcting deficiencies Hoque2016Drexler2020.
Iron Overload and Hemochromatosis
In hereditary hemochromatosis, especially among individuals with the C282Y HFE gene mutation, both serum ferritin and TSAT are often elevated. Most C282Y homozygotes have high TSAT and ferritin, but the prevalence of this mutation varies by ethnicity, being most common in non-Hispanic whites. Notably, high TSAT and ferritin are not exclusive to those with this mutation, as some nonwhite populations also show elevated levels despite low mutation rates .
Both very high and very low TSAT and plasma iron are linked to increased risk of infections. Individuals with hemochromatosis (C282Y homozygosity) have a higher risk of infections, even if their iron markers are within normal ranges, suggesting that genetic factors play a role beyond just iron levels .
Chronic Diseases and Iron Markers
In chronic kidney disease and other inflammatory states, interpreting TSAT and ferritin can be challenging. Ferritin is an acute-phase reactant and may be elevated due to inflammation, while TSAT may be low, leading to conflicting results. Newer markers, such as reticulocyte hemoglobin content and soluble transferrin receptor, may help clarify iron status in these cases .
Iron Saturation and Disease Risk
Elevated TSAT, serum iron, and ferritin are associated with an increased risk of type 2 diabetes, while lower transferrin levels are linked to a reduced risk. Genetic evidence also supports a connection between higher systemic iron status and greater diabetes risk .
Interestingly, while high ferritin is associated with accelerated biological aging, higher serum iron and TSAT are inversely associated with some aging metrics, indicating a complex relationship between iron status and aging processes .
Emerging Markers for Iron Overload
In patients receiving regular blood transfusions, glycosylated ferritin is emerging as a promising marker for iron overload. It correlates well with TSAT and serum ferritin, and may be more specific for transfusion-related iron overload, with a proposed cutoff of >587.55 ng/mL for diagnosis .
Conclusion
Iron saturation levels in blood, primarily measured as transferrin saturation, are essential for evaluating iron status, diagnosing deficiencies, and monitoring for overload. Reference ranges vary by age, sex, and physiological state. Both low and high TSAT can have health implications, including increased infection risk and associations with chronic diseases. Accurate interpretation requires consideration of individual factors, comorbidities, and, in some cases, genetic background. Newer markers like glycosylated ferritin may further improve assessment in specific populations.
Sources and full results
Most relevant research papers on this topic